ACTG Presents Study at CROI Demonstrating Increased Risk of Obesity and Cardiometabolic Disease After Switch to Integrase Inhibitor-Containing Regimen
ACTG, a global clinical trials network focused on HIV and other infectious diseases, today presented data demonstrating that switching to an integrase inhibitor-based antiretroviral regimen increased ...
Medscape2d
Omalizumab vs Oral Immunotherapy: No Clear Winner
In the trials, omalizumab and multi-allergen oral immunotherapy showed alike efficacy in protecting against food allergies, ...
Research identifies key antibodies for development of broadly protective norovirus vaccine
Scientists have discovered a strategy to fight back against norovirus, a leading cause of gastroenteritis worldwide. Their ...
News-Medical.Net on MSN8d
Scientists discover new strategy to fight back against norovirus
Scientists at The University of Texas at Austin, in collaboration with researchers from the University of North Carolina at Chapel Hill and the National Institutes of Health, have discovered a ...
News Medical on MSN1d
HPTN 094 study examines a novel way to take addiction care and HIV prevention to people who inject drugs
Researchers from the HIV Prevention Trials Network (HPTN) presented results from the HPTN 094 (“INTEGRA”) study at the 2025 ...
Science Daily9d
Research identifies key antibodies for development of broadly protective norovirus vaccine
Scientists at The University of Texas at Austin, in collaboration with researchers from the University of North ... funded by the National Institute of Allergy and Infectious Disease at the ...
ACTG Presents Data From Mpox Study STOMP At CROI
Tecovirimat is Safe but Not Efficacious in People with Clade II Mpox Today's presentation, which was highlighted in a CROI press conference, found that tecovirimat did not reduce the time to clinical ...
ACTG Presents Important Findings from REPRIEVE at CROI 2025
To learn more, please visit www.reprievetrial.org.
manilatimes3d
ACTG Presents Four Studies at CROI Describing Findings from SLIM LIVER
Eron, M.D., University of North Carolina ... It is sponsored by the National Institutes of Health's (NIH) National Institute of Allergy and Infectious Diseases (NIAID, which also funds ACTG) under ...